Clinical Trials Logo

Transplant Rejection clinical trials

View clinical trials related to Transplant Rejection.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05156710 Recruiting - Clinical trials for Transplant Rejection

BIVV020 (SAR445088) n Prevention and Treatment of Antibody-mediated Rejection (AMR)

Start date: June 9, 2022
Phase: Phase 2
Study type: Interventional

Primary Objectives: - Cohort A: To evaluate the efficacy of BIVV020 in prevention of AMR - Cohort B: To evaluate the efficacy of BIVV020 in treatment of active AMR Secondary Objectives: - To assess the overall efficacy of BIVV020 in prevention or treatment of AMR - To characterize the safety and tolerability of BIVV020 in kidney transplant participants - To characterize the pharmacokinetic (PK) profile of BIVV020 in kidney transplant participants - To evaluate the immunogenicity of BIVV020

NCT ID: NCT04615221 Recruiting - Clinical trials for Transplant Rejection

Immunological Mechanisms of Rejection in Uterine Transplantation

MARNI
Start date: September 21, 2020
Phase: N/A
Study type: Interventional

The objective of this study is to understand the mechanisms of rejection in uterine transplantation and to search for non-invasive markers of rejection. The biological samples necessary for our research have been or will be collected during procedures (biopsies, smears, vaginal swab, blood tests) carried out as part of the scheduled follow-up of patients. These will be samples whose collection is minimally or not invasive

NCT ID: NCT03984747 Recruiting - Complications Clinical Trials

Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA Detection

SPARO
Start date: September 14, 2018
Phase:
Study type: Observational

This is a multi-center prospective study designed to collect blood samples from transplant patients in order to improve Natera's method for determining allograft rejection status using the donor-derived cell-free DNA analysis, called Prospera.